Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chloé Talarmin"'
Autor:
Chloé Talarmin-Gas, Georges Smolyakov, Cleo Parisi, Cyril Scandola, Valérie Andrianasolonirina, Cloé Lecoq, Valentine Houtart, Song-Hua Lee, Homa Adle-Biassette, Bénédicte Thiébot, Timothy Ganderton, Philippe Manivet
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-15 (2024)
Abstract MandibuloAcral Dysplasia associated to MTX2 gene (MADaM) is a recently described progeroid syndrome (accelerated aging disease) whose clinical manifestations include skin abnormalities, growth retardation, and cardiovascular diseases. We pre
Externí odkaz:
https://doaj.org/article/1dbb1081659043f4b03a5d849a79099d
Autor:
Emmanuelle Clou, Antonin Dubois, Julien Gaudas, Hugo Palisson, Kahina Chetouane, Chloé Talarmin, Olivia Meynial, Jacqueline Nguyen, Sandra Assoun, Marc-Antoine Benderra, Dhekra Nasrallah, Adoraction Esteso, Danièle Avenin, Gilles Galula, Djamel Ghebriou, Joseph Gligorov, Ahmed Khalil, Clément Korenbaum, Coralie Prebet, Hervé Foka-Tichoue, Jean-Pierre Lotz, Isabelle Debrix
Publikováno v:
European Journal of Oncology Pharmacy. 5:e00033
Autor:
Eden Schwartz, Nicolas Boissel, Anne Brignier, Isabelle Madelaine, Nathalie Parquet, André Desproges, Sarah Mukenyi, Lorène Magdelonnette, Chloé Talarmin, Emmanuelle Lesprit, André Baruchel, Catherine Thieblemont, Steven Kerob, Jérôme Larghero, Miryam Mebarki, François Cartier
Publikováno v:
Cytotherapy
Cytotherapy, Elsevier, 2020, 22, pp.792-801. ⟨10.1016/j.jcyt.2020.06.009⟩
Cytotherapy, 2020, 22, pp.792-801. ⟨10.1016/j.jcyt.2020.06.009⟩
Cytotherapy, Elsevier, 2020, 22, pp.792-801. ⟨10.1016/j.jcyt.2020.06.009⟩
Cytotherapy, 2020, 22, pp.792-801. ⟨10.1016/j.jcyt.2020.06.009⟩
International audience; Background aims: According to European Directive 2001/83/EC, chimeric antigen receptor T (CAR T) cells belong to a new class of medicines referred to as advanced therapy medicinal products (ATMPs). The specific features and co
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 51:351-352
Introduction D’apres l’enquete de l’inspection generale des affaires sociales (IGAS) 2014-168R, 45 % des poches prescrites en neonatalogie, sont soit des specialites dotees d’une AMM (22 %) soit des preparations hospitalieres standardisees (2